Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Charlotte Marcus"'
Publikováno v:
Gynecologic Oncology Reports, Vol 14, Iss C, Pp 1-3 (2015)
Externí odkaz:
https://doaj.org/article/3213c840156f4dc0a26143a847de19a8
Autor:
Thomas P. Conrads, Pang Ning Teng, Elizabeth A. Dubil, Kelly A. Conrads, Chad A. Hamilton, Guisong Wang, Kathleen M. Darcy, Nicholas W. Bateman, Lisa A. Vasicek, Keren Paz, Wei Ao, G. Larry Maxwell, Neil T. Phippen, William P. McGuire, Elizabeth Jaworski, Brian L. Hood, David Sidransky, Charlotte Marcus, Tracy Litzi
Publikováno v:
Journal of Proteome Research. 14:1900-1910
A majority of high-grade (HG) serous ovarian cancer (SOC) patients develop resistant disease despite high initial response rates to platinum/paclitaxel-based chemotherapy. We identified shed/secreted proteins in preclinical models of paclitaxel-resis
Publikováno v:
Gynecologic Oncology Reports, Vol 14, Iss C, Pp 1-3 (2015)
Gynecologic Oncology Reports
Gynecologic Oncology Reports
Highlights • Anti-NMDA-receptor encephalitis is a paraneoplastic syndrome caused by teratomas. • The syndrome includes psychiatric symptoms followed by autonomic dysregulation. • Rapid diagnosis and removal of the tumor is essential for optimiz
Publikováno v:
Journal of Cancer
Epithelial ovarian cancer is the leading cause of death among gynecologic malignancies. Treatment of recurrent ovarian cancer remains a challenge despite advances in surgical and chemotherapeutic options. A goal of many providers is to detect recurre
Autor:
Thomas P. Conrads, Michael J. Becich, Roger Day, Uma R. Chandran, John I. Risinger, Chad A. Hamilton, Charlotte Marcus, Caela Miller, Christopher M. Zahn, Kevin Byrd, Julie Oliver, Yovanni Cassablanca, Jay E. Allard, Elizabeth A. Dubil, Kathleen M. Darcy, G. Larry Maxwell, Gadisetti V.R. Chandramouli, Tracy Litzi, Andrew Berchuck
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 3 (2013)
Frontiers in Oncology, Vol 3 (2013)
Endometrial cancer is the most common gynecologic malignancy in the United States but it remains poorly understood at the molecular level. This investigation was conducted to specifically assess whether gene expression changes underlie the clinical a
Autor:
Kelly A. Conrads, Elizabeth A. Dubil, Nicholas W. Bateman, Guisong Wang, Kathleen M. Darcy, Elizabeth Jaworski, Brian L. Hood, Thomas P. Conrads, Chad A. Hamilton, Charlotte Marcus, Pang-ning Teng, Larry G. Maxwell
Publikováno v:
Cancer Research. 75:4631-4631
Objective: Although most ovarian cancer patients respond initially to the standard of care involving carboplatinum/paclitaxel-based chemotherapy, the majority will recur with chemotherapeutically resistant disease. Unfortunately, no clinical biomarke